Screener
Biohaven BHVN Fair Value Measurement Disclosure
Fair Value Measurement Disclosure at other companies
Other financials
Where this comes from
Reported directly by Biohaven in its filing.
Tagged under the XBRL concept us-gaap:FinancialLiabilitiesFairValueDisclosure.
The source filing: Biohaven’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001935979-26-000045
| Balance Sheet Classification / March 31, 2026 | Type of Instrument | Fair Value Measurement Using: / Level 1 | Fair Value Measurement Using: / Level 2 | Fair Value Measurement Using: / Level 3 | Fair Value Measurement Using: / Total |
|---|---|---|---|---|---|
| Total assets | $182,845 | $140,561 | — | $323,406 | |
| Liabilities: | |||||
| Notes payable | Notes payable, non-current | — | — | 241,912 | 241,912 |
| Total liabilities | — | — | $241,912 | $241,912 | |
| December 31, 2025 | |||||
| Assets: | |||||
| Cash and cash equivalents | Money market funds | $195,265 | — | — | $195,265 |
| Cash and cash equivalents | U.S. treasury bills | — | 24,990 | — | 24,990 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Biohaven's fair value measurement disclosure?
- Biohaven (BHVN) reported fair value measurement disclosure of $241.91M in Q1 2026.
- What does fair value measurement disclosure mean?
- This represents the aggregate carrying amount of assets and liabilities that are measured at fair value on a recurring or non-recurring basis. It provides transparency into the valuation techniques and inputs used to determine these values, categorized by the fair value hierarchy. This is critical for asset managers holding diverse investment portfolios.
Ask your AI about Biohaven's fair value measurement disclosure.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude